Recall of MGC Health Cough Drops Announced
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. is voluntarily recalling certain lots of MGC Health Cough Drops due to potential quality issues identified by the FDA during a facility inspection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Drugs.
Recall Article
What Happened
This recall was initiated following FDA's recommendation based on observations noted during an August 15, 2025, inspection of the manufacturing facility that may affect product quality.
Which Products Are Affected
The affected products are MGC Health Menthol Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, in 25-count bags. Specific details include: NDC 83698-125-25, UPC 383173000085, package NDCs 83698-125-25 and 83698-125-70, and lots Lot# 20240524 with expiration date 05/24/2026, Lot# 20240720 with expiration date 07/20/2026, and Lot# 20240730 with expiration date 07/30/2026. The recall involves products distributed US Nationwide, with the quantity not specified.
What You Should Do
Consumers who have the affected products should follow the initial firm notification via letter and contact the recalling firm, Xiamen Kang Zhongyuan Biotechnology Co., Ltd., for further instructions.
Why This Matters
This recall addresses potential quality concerns in over-the-counter drugs, which could impact consumer safety, and it affects products distributed nationwide.
Source
FDA Recall Number: D-0461-2026. For more information, refer to the FDA website at https://www.fda.gov/.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,258 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.